HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakayama, M. Articles by Kasuga, M. Search for Related Content PubMed PubMed Citation Articles by Nakayama, M. Articles by Kasuga, M. Social Bookmarking                What's this?

Fas/Fas Ligand Interactions Play an Essential Role in the Initiation of Murine Autoimmune Diabetes

¹ Department of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe, Japan
² Department of Internal and Geriatric Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
³ Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan

Apoptosis via Fas/Fas ligand (FasL) interactions has been proposed to be a major T-cell-mediated effector mechanism in autoimmune diabetes. To elucidate the role of Fas/FasL interactions in NOD diabetes, the effects of neutralizing anti-FasL antibody on autoimmune responses were evaluated. Islet-specific CD8⁺ and CD4⁺ T-cells expressed FasL upon activation and mediated FasL-dependent cytotoxicity against Fas-expressing target cells in vitro, although their cytotoxicity against islet cells was not blocked by anti-FasL antibody. Moreover, administration of anti-FasL antibody failed to inhibit diabetes in vivo in the CD8⁺ T-cell adoptive transfer model. On the other hand, blockade of Fas/FasL interactions significantly inhibited CD4⁺ T-cell-dependent diabetes in adoptive transfer models. These results suggest a substantial contribution of Fas/FasL interactions to CD4⁺, but not CD8⁺, T-cell-mediated destruction of pancreatic ß-cells. When anti-FasL antibody was administered to NOD mice between 5 and 15 weeks of age, the onset of diabetes was slightly delayed but the incidence was not decreased. However, administration of anti-FasL antibody at 2–4 weeks of age completely prevented insulitis and diabetes. These results suggest that Fas/FasL interactions contribute to CD4⁺ T-cell-mediated ß-cell destruction and play an essential role in the initiation of autoimmune NOD diabetes.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Allison, H. E. Thomas, T. Catterall, T. W. H. Kay, and A. Strasser Transgenic Expression of Dominant-Negative Fas-Associated Death Domain Protein in {beta} Cells Protects against Fas Ligand-Induced Apoptosis and Reduces Spontaneous Diabetes in Nonobese Diabetic Mice J. Immunol., July 1, 2005; 175(1): 293 - 301. [Abstract] [Full Text] [PDF]

				L. Vence, C. Benoist, and D. Mathis Fas Deficiency Prevents Type 1 Diabetes by Inducing Hyporesponsiveness in Islet {beta}-Cell-Reactive T-Cells Diabetes, November 1, 2004; 53(11): 2797 - 2803. [Abstract] [Full Text] [PDF]

				H. Qin, J. D. Trudeau, G. S. D. Reid, I-F. Lee, J. P. Dutz, P. Santamaria, C. B. Verchere, and R. Tan Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL Int. Immunol., November 1, 2004; 16(11): 1657 - 1662. [Abstract] [Full Text] [PDF]

				P. Augstein, P. Heinke, E. Salzsieder, S. Berg, R. Rettig, C. Salzsieder, and L. C. Harrison Fas Ligand Down-Regulates Cytokine-Induced Fas Receptor Expression on Insulinoma (NIT-1), But Not Islet Cells, from Autoimmune Nonobese Diabetic Mice Endocrinology, June 1, 2004; 145(6): 2747 - 2752. [Abstract] [Full Text] [PDF]

				I. Apostolou, Z. Hao, K. Rajewsky, and H. von Boehmer Effective Destruction of Fas-deficient Insulin-producing {beta} Cells in Type 1 Diabetes J. Exp. Med., October 6, 2003; 198(7): 1103 - 1106. [Abstract] [Full Text] [PDF]

				R. Darwiche, M. M. W. Chong, P. Santamaria, H. E. Thomas, and T. W. H. Kay Fas Is Detectable on {beta} Cells in Accelerated, But Not Spontaneous, Diabetes in Nonobese Diabetic Mice J. Immunol., June 15, 2003; 170(12): 6292 - 6297. [Abstract] [Full Text] [PDF]

				A. Y. Savinov, A. Tcherepanov, E. A. Green, R. A. Flavell, and A. V. Chervonsky Contribution of Fas to diabetes development PNAS, January 21, 2003; 100(2): 628 - 632. [Abstract] [Full Text] [PDF]